In hematopoiesis the evolution of specialized cell lineages from a common stem cell is mediated by lineage-specific growth factors. The role of DNA methylation in the multilevel regulation of the differential gene expression, especially in the case of growth factor receptor genes, has remained elusive. In earlier studies we showed a lineage-specific methylation pattern of the M-CSF receptor gene c-fms in blood monocytes and tissue macrophages. Here, we provide evidence that a lineagespecific hypomethylation exists for the G-CSF receptor gene for myelomonocytic cells but not in lymphocytes without any interindividual differences. Constant differences were found between alveolar and peritoneal macrophages with a lesser degree of methylation in peritoneal macrophages. Acute myelomonocytic leukemias showed an increased methylation as compared with normal granulocytes and monocytes. All permanent cell lines analyzed revealed hypermethylation of the G-CSF receptor gene. Lymphocytes of B-CLL showed a strong hypermethylation of this gene. Increased methylation has been shown to be inversely correlated with transcriptional gene activities. We conclude that the methylation pattern of growth factor receptor genes may be one of the regulatory mechanisms in multi-lineage differentiation.
Introduction
About 4% of all cytosine residues are methylated in mammalian DNA. 1, 2 This epigenetic modification is established in a tissue-specific manner during embryogenesis and is faithfully copied after cell replication, leading to tissue-specific methylation patterns. 1, 3 The role of DNA methylation is only partially understood. This type of DNA modification has been associated with the imprinting of maternal and paternal genes 4, 5 and with the long-term silencing of genes or gene groups in X-dosage compensation. 6 For some genes a clear inverse correlation between the extent of methylation of the promoter region and expression activity has been described. 7, 8 Methylated cytosine binding proteins (MeCPs) have been identified, 9, 10 which specifically bind to methylated DNA inhibiting transcription at the promoter region. 11 CpG islands seen in housekeeping genes are not subject to methylation unless located in inactivated X-chromosomes or involved in genetic imprinting.
The regulation of the diverse and lineage-specific differentiation from a common pluripotent hematopoietic stem cell is mediated by concerted activity of a large number of growth factors. 12 A prerequisite for this lineage-specific development is the selective expression of specific growth factor receptors. Some of the growth factors and their corresponding receptors for the granulocytic and monocytic lineages have been unraveled. For the M-CSF receptor gene c-fms we could show a lineage-specific methylation in normal blood cells. Normal monocytes and monocyte-derived macrophages, which are known to overtly express the M-CSF receptor, the c-fms gene product, were shown to be significantly hypomethylated in the upstream region preceding the second exon of the gene. Leukocytes lacking the M-CSF receptor protein such as granulocytes, T and B lymphocytes regularly reveal hypermethylation of this gene segment. 13 Despite such regular behavior of normal leukocytes, leukemic myelomonocytic cells, irrespective of their c-fms gene expression on messenger RNA level, show hypermethylation of the same gene segment.
14 Hence, in neoplastic cells, hypermethylation of the gene promoter region may not prevent its expression, at least at the mRNA level.
In the granulocytic lineage growth and functional activities are regulated by the G-CSF for which these cells express the corresponding receptor. 15 The G-CSF receptor gene is located on chromosome 1, region p35-p34.3. 16 It is about 16.5 kb long and consists of 17 exons. 17 The promoter localizes to a 1100 bp upstream stretch containing GF1, AP1 and AP2 binding sites as well as C/EBP− and PU.1 recognition segment. 17, 18 In a study looking for a lineage-specific methylation pattern under normal and neoplastic conditions we investigated the promoter region within the G-CSF receptor gene by use of methylation-sensitive restriction enzymes in normal leukocytes, tissue macrophages and in some leukemias as well as in permanent cell lines.
Materials and methods
DNA of normal granulocytes, monocytes and lymphocytes was extracted from the blood of healthy volunteers as described. 19 Alveolar and peritoneal macrophages with a high purity rate were also included in the study. 20 In addition, 15 leukemia cases covering acute non-lymphocytic leukemia of M2, M4 and M5 subtypes as well as 15 typical cases of B-CLL were included. 14 Cell lines consisted of the promonocytic cell line U937, the myeloblastic cell line K562 and the T lymphoblastic cell line HUT78, all from the American Type Culture Collection (ATCC, Rockville, MD, USA). Ma2, an EBV-driven lymphoblastoid cell line established in our own laboratory, was also included. The cells were maintained under standard culture conditions. DNA of purified cells was extracted as described. 19 DNA of normal blood cells and cell lines was first digested with the enzymes EcoRI and XhoI or BamHI (BoehringerMannheim, Germany). The methylation-sensitive restriction steps were performed with HpaII, HhaI or SmaI, which cut DNA only if the specific recognition sequences were not inhibited by methyl moieties. 21 Restriction was performed with an excess of enzyme as described. 13 After electrophoresis through 0.85% (w/v) agarose gels and Southern blot transfer to coated nylon membranes (Genescreen, New England Nuclear, Boston, MA, USA) 22 hybridization was performed with a PCR generated DNA probe (promoter probe) of the 5′ end of the G-CSF receptor gene according to the published sequence. 17 The primers used for the generation of the promoter probe were CCT GTT TCT CCA TCT GCC TGG (5′ primer) and CTA AGC CTC TTT TCA GCT CTA (3′ primer). The resulting 160 bp promoter probe was controlled by sequencing. 23 This probe was labeled with 32 P-deoxycytidine-triphosphate (3000 Ci/mmol; Amersham, Braunschweig, Germany) to specific radioactivities of 1.5 × 10 9 -3 × 10 9 c.p.m./mg DNA using the PCR primers instead of random primers. After prehybridization and hybridization and washing as described, 13 blots were exposed to X-ray films (Hyperfilm-MP; Amersham) with an intensifying screen at −70°C for 1 day and up to 14 days. Densitometric analysis was performed using a Flying Spot densitometer (Kontron, Eching, Germany). The bands were measured on short time exposed blots. All bands in a lane were analyzed together and the relative intensity of one band was expressed as a fraction of the intensity of all bands in the lane.
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Results
We investigated the methylation status of the G-CSF receptor gene in normal and neoplastic leukocytes. Figure 1 shows the 5′ -region of the G-CSF receptor gene containing the promoter region and exon 1. 16 The restriction sites for HpaII, HhaI and SmaI are numbered 1-6. The cleavage sites 1-3 and 5 are HpaII sites. In addition, 3 and 5 represent SmaI cutting sites. Two restriction sites for HhaI exist, one is located between the two SmaI restriction sites and has been referred to as number 4; a second HhaI site (number 6) is located within the first intron.
Granulocytes (G) and monocytes (M) showed a complete demethylation of HpaII site 1 resulting in one band of 0.16 kb length ( Figure 2 , donor 1). Compared to this pattern in normal lymphocytes (L) two stronger bands could be seen corresponding to the HpaII sites 2 (0.29 kb) and 3 (0.36 kb). This indicates that site 1 is completely methylated in lymphocytes, while site 2 is partially methylated. Also, site 3 seems to be only partially methylated because a faint band was detectable at 0.48 kb corresponding to site 5.
In Table 1 methylation of restriction site 1 is graded from 0 to III according to the intensity of the corresponding band. Granulocytes and monocytes do not exhibit any methylation of site 1 and are classified as group 0, while lymphocytes which show a nearly complete methylation belong to group III.
More information was revealed about restriction site 3 by using SmaI instead of HpaII ( Figure 2 , donor 2). Restriction of granulocytic, lymphocytic and monocytic DNA with EcoRI and SmaI resulted in a strong band of 0.36 kb after hybridiz- Figure 1 Restriction map of the G-CSF-receptor gene encompassing the promoter probe region and exon 1 (black bars). ation with the promoter probe in all three cell fractions. Only in lymphocytes was an additional faint band of 0.48 kb detected, implying that site 3, which is completely demethylated in granulocytes and monocytes, is methylated to approximately 10% as judged by densitometry. The regular complete demethylation of granulocytes and monocytes at site 3 rendered methylation analysis of the downstream site 5 impossible in these cells.
HhaI site 4 ( Figure 1 ) revealed a similar methylation pattern as compared to the HpaII sites. After restriction with EcoRI, XhoI and HhaI (Figure 2, donor 3) we could see in granulocytes a strong band at 0.43 kb corresponding to a complete demethylation of site 4. In monocytes a weak methylation of this site could be seen by the occurrence of faint larger bands. In lymphocytes this site showed methylation of approximately 80% resulting in greater fragments of 0.91 and 1.23 kb lengths.
Permanent cell lines included here did not reveal a constant lineage-specific methylation pattern after restriction with HhaI (0 = no methylation, I = less than 10%, II = 10-50%, III = more than 50%).
Figure 3
Methylation pattern of alveolar and peritoneal macrophages after restriction with BamHI and HpaII. The use of BamHI instead of EcoRI and XhoI leads to an elongation of the resulting bands, but the relative position of bands remain unchanged. A weak methylation of HpaII site 1 was seen in peritoneal macrophages (PM, samples 4-6) resulting in a strong fragment of 0.97 kb, while alveolar macrophages (AM, samples 1-3) showed a higher methylation of this restriction site with occurrence of a stronger 1.10 kb fragment compared to monocytes (M). Blast populations of acute myeloid leukemias (AML) showed a strong 0.97 kb fragment indicating a strong demethylation of site 1 but in most probes an additional more or less faint 1.10 kb fragment occurred indicating a weak methylation of site 1. Chronic lymphocytic leukemias (CLL) revealed an inconstant methylation pattern with a hemimethylation of the first site resulting in two fragments of the same intensity. One probe was hypermethylated in this site (lane 2), while in three probes a hypomethylation of the same locus occurred resulting in a strong 0.97 kb band (lane 5). methylation has been found to be considerably enhanced to approximately 80% of the total lane density.
Purified blast populations (less than 5% lymphocytes) of acute myelomonocytic leukemias showed a slight increase in methylation of the first HpaII site within the G-CSF receptor gene as compared to granulocytes and monocytes. After restriction with BamHI and HpaII a strong band of 0.97 kb (Figure 3 , AML) appeared indicating a high demethylation of the first HpaII site (Figure 1) . In most leukemia samples a faint 1.1 kb fragment appeared, corresponding to a methylation degree of less than 10% in site 1 (Table 1, I) but three samples showed a methylation degree of more than 10% (Table 1 , II) in this site which could not have been attributed to lymphocyte contamination. There was no correlation between DNA methylation and the immunophenotype of the leukemic blasts (data not shown). None of the cases of acute myelomonocytic leukemia revealed complete demethylation of site 1 as could be seen in normal blood granulocytes.
The methylation pattern in B-CLL (Figure 3 , CLL) varied (Table 1 , I-III). Most samples showed hemimethylation of the first HpaII site. One single probe revealed hypermethylation of site 1, while three probes showed a hypomethylation similar to that of granulocytes (Figure 3, CLL lane 5) .
Discussion
The mechanisms which regulate the lineage-specific expression of genes in normal cells are only partially understood. For some functional genes such as the myeloperoxidase gene or the globin gene a correlation between methylation of the promoter region and gene expression could be demonstrated. 8, 26 An additional example is the c-fms gene encoding the M-CSF receptor protein for which a selective mRNA expression, as well as cell-specific hypomethylation of the 5′ region in monocytes, 13, 14 was reported previously by our laboratory. Methylation of the promoter region influences the interaction of transcription factors with the DNA either by changing the conformation, by direct inhibition through methyl moieties or by binding of specific MeCPs. 9, 27 Thus, the methylation pattern of a gene in the promoter region seems to be at least one element in the regulation of differential gene activity and expression of cell phenotype for some genes in certain cell types.
Paroush et al 28 showed that the demethylation of critical CpG loci in the rat alpha-actin gene promoter is essential for transcriptional activation. However, it has also been debated whether methylation of genes is the cause or the consequence of non-expression. Yisraeli et al 29 transfected in vitro methylated alpha-actin (skeletal) gene constructs into fibroblasts and myoblasts. The transfected alpha-actin gene was not found to be expressed in the fibroblasts, whereas in the myoblasts a cell-specific demethylation with an overt expression of the transfected gene occurred. Enver et al 30 investigated the methylation behavior of the globin gene during the switch from gamma-to beta-globin comparing fetal and adult erythroid cells. In this case it could be shown that methylation of the gamma-globin gene appeared after inactivation of this gene during the globin switch.
On protein level in human hematopoietic cells the G-CSF receptor gene is strongly expressed in granulocytes, whereas monocytes show a low level of receptor protein expression and lymphocytes constantly lack the G-CSF receptor. 31, 32 This expression pattern correlates well with the degree of methylation of HpaII restriction site 1 (Figure 1 ). Demethylation may reflect transcriptional events required for the cell phenotype. In this respect, a parallel behavior has been detected with the c-fms gene coding for the monocyte/macrophage colonystimulating factor receptor in monocytes and monocytederived tissue macrophages. 13 For quantification of methylation we performed densitometry of radiographic films. The relation between X-ray signal and the measured values is only partly linear, and this has to be considered. In this method it is important to measure short time exposed films only because overexposure results in a saturation of the density of the X-ray film leading to incorrect band intensities. 24 Because not only exposition time but also the background signal influences the measured intensities we classified these intensities only in three groups for the purpose of a rough or semiquantitative estimate (Table 1) .
Lymphocytes which are known to lack G-CSF receptor, consistently exhibited hypermethylation of the promoter region of this gene. The human G-CSF receptor is selectively expressed in mature granulocytes, granulocytic precursors and to a lesser extent in monocytes. 31 Granulocytes and monocytes develop from a close common precursor cell, eg the promyelocyte in the bone marrow. 33, 34 Probably, the methylation pattern of the 5′ G-CSF receptor gene region is preserved from this precursor cell through polymorphonuclear granulocytes and to a lesser extent in monocytes. It is also conceivable that monocytes additionally acquire methyl moieties alongside their further differentiation pathway into resident tissue macrophages reflecting the gradual deactivation of the relevant gene. This would imply that peritoneal macrophages which exhibit a low degree of methylation of the G-CSF receptor gene come next to monocytes and that alveolar macrophages revealing a high degree of methylation of this gene region represent a further stage of differentiation.
In permanent cell lines the methylation pattern of the G-CSF receptor gene was inconstant. While U937 showed complete demethylation as expected from granulocytes, other myeloid or lymphoid cell lines showed atypical hypermethylation patterns. It is known that the methylation pattern may change in transformed cells and under long-term culture conditions. Probably, cells with a low degree of differentiation and hypermethylation of many genes have a growth advantage under in vitro culture conditions.
Although malignant transformation and long-term cultures may result in unpredictable changes in the methylation pattern of functionally important genes, our results provide evidence that differential methylation of growth factor receptor genes may be at least one mechanism regulating the differentiation pathway of the pluripotent precursor cells in the normal hematopoietic multilineage development.
Most cases of acute myelomonocytic leukemias showed only a weak increase in the G-CSF receptor gene methylation as compared to normal granulocytes. This is in line with the finding that the G-CSF receptor protein is expressed in many cases of acute non-lymphocytic leukemias. 35 As expected, most cases of B-CLL showed a strong hypermethylation of the first HpaII restriction site coarsely resembling normal lymphocytes. A few cases, however, revealed complete hypomethylation despite their unequivocal derivation from lymphocyte lineage.
A recently developed methylation analysis technique employs bisulfite modification of cytosin to uracil. The following comparative sequencing of the PCR amplified DNA discloses the methylation sites. 36, 37 This technique might be preferable to the Southern blot method used in our experiments in that it determines the complete methylation status of all CpG sites. The use of methylation-sensitive restriction enzymes may focus mainly on a small portion of the methylated sites leading to an overall underestimation of DNA methylation. Another advantage of the bisulfite modification technique is its independence of large amounts of DNA. Nevertheless, it has been debated that in the bisulfite modification technique unmethylated CpG sites might be more readily amplified than methylated sites leading to a phenomenon referred to as 'bias effects', 38 which can lead to an underestimation of DNA methylation. To avoid this it is necessary to perform mixing experiments with the sequence of interest in the unmethylated and completely methylated state.
We applied the methylation-sensitive restriction enzyme technique in the present study to enable comparison with our earlier results. Beyond that, the aim of the present study was mainly to detect similarities in the methylation patterns between closely related cell populations. The availability of the new PCR-based techniques of methylation analysis enables examination of the differential methylation patterns of the cell cohorts upstream in the hematopoietic lineage.
